U.S. markets closed

PolarityTE, Inc. (PTE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9120-0.0647 (-6.62%)
At close: 4:00PM EDT

0.9198 +0.01 (0.86%)
After hours: 4:00PM EDT

PolarityTE, Inc.

1960 South 4250 West
Salt Lake City, UT 84104
United States
800 560 3983
http://www.polarityte.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees80

Key Executives

NameTitlePayExercisedYear Born
Mr. David B. SeaburgChief Exec. Officer680.07kN/A1970
Mr. Richard HaguePres & COO649.26kN/A1960
Mr. Cameron J. HoylerGen. Counsel, Sec. and Exec. VP of Corp. Devel. & Strategy623.19kN/A1984
Mr. Jacob Alexander PattersonInterim Chief Financial OfficerN/AN/A1979
Mr. Nikolai SopkoChief Scientific Officer and VP of R&DN/AN/AN/A
Mr. Rich HaerleVP of Investor Relations & StrategyN/AN/AN/A
Angela ZieglerVP of Marketing & PRN/AN/AN/A
Mr. Alain AdamVP of SalesN/AN/AN/A
Dr. Edward Winslow SwansonChief Medical Officer & Co-FounderN/AN/A1985
Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACSChief Clinical Officer & Member of Clinical Advisory BoardN/AN/A1949
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PolarityTE, Inc., a biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates through two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and OsteoTE. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.